Shockwave Medical, Inc. (“Shockwave”) owns U.S. Patent No. 8,956,371 (“the ’371 patent”). This patent is directed to the treatment of atherosclerosis through intravascular lithotripsy (“IVL”). The ...

The Federal Circuit recently issued a precedential decision in Shockwave Med., Inc. v. Cardiovascular Sys., Inc. (CSI), affirming-in-part and reversing-in-part the Patent Trial and Appeal Board’s ...

Please provide your email address to receive an email when new articles are posted on . Orbital atherectomy was no better than balloon angioplasty for treatment of certain severely calcified coronary ...

Results from the first randomized controlled trial to directly compare the safety and efficacy of cutting balloon (CB) angioplasty to intravascular lithotripsy (IVL) prior to drug-eluting stent (DES) ...

SANTA CLARA, Calif., June 28, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. About one in six patients who undergo balloon angioplasty to open a ...

Angioplasty is a treatment for deep vein thrombosis (DVT), which is a blood clot that forms in one of the deep veins typically in your legs. DVT can partly or totally block the blood flow back to your ...

Balloon pulmonary angioplasty improved exercise capacity and quality of life in patients with chronic thromboembolic pulmonary hypertension (CTEPH). The procedure could be an option for inoperable ...

Boston, MA - A paclitaxel-coated balloon may end up filling a role never successfully filled by drug-eluting stents (DES): angioplasty of the leg. According to Dr Gunnar Tepe ...